ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»ppharm-476Research ArticleДИАГНОСТИКА В ПЕДИАТРИИPEDIATRIC DIAGNOSTICSРЕБЕНОК С ГЕМОРРАГИЧЕСКОЙ СЫПЬЮCHILD WITH HEMORRHAGIC RASHРедакционнаястатьяEditorialArticle2015210820151219798Copyright © Редакционная с., 20152015Редакционная с.Editorial a.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/476
.
.
ReferencesNeunert C., Lim W., Crowther M., Cohen A., Solberg L., Crowther M. A. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011 Apr 21; 117 (16): 4190–207.Neunert C., Lim W., Crowther M., Cohen A., Solberg L., Crowther M. A. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011 Apr 21; 117 (16): 4190–207.Schultz C. L., Mitra N., Schapira M. M., Lambert M. P. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia. JAMA Pediatr. 2014 Oct; 168 (10): e142214.Schultz C. L., Mitra N., Schapira M. M., Lambert M. P. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia. JAMA Pediatr. 2014 Oct; 168 (10): e142214.Khellaf M., Charles-Nelson A., Fain O., Terriou L., Viallard J. F., Cheze S. et al. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients. Blood. 2014 Nov 20; 124 (22): 3228–36.Khellaf M., Charles-Nelson A., Fain O., Terriou L., Viallard J. F., Cheze S. et al. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients. Blood. 2014 Nov 20; 124 (22): 3228–36.
The authors declare that there are no conflicts of interest present.